Burning, blisters, pain: More than 40 million people worldwide are infected with the herpes virus every year. The virus can pose a serious threat to newborns and people with weakened immune systems. Researchers in Hamburg and Göttingen have now generated a mini-antibody that neutralizes a protein essential for the infection. The findings, published in Nature, hold the promise of new therapies to treat and prevent severe herpes infections in the near future.
Alpaca-generated nanobody neutralizes a protein essential for herpes infection
